These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
438 related items for PubMed ID: 17074265
41. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476 [Abstract] [Full Text] [Related]
42. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Quy HT, Lan NT, Borgdorff MW, Grosset J, Linh PD, Tung LB, van Soolingen D, Raviglione M, Cô NV, Broekmans J. Int J Tuberc Lung Dis; 2003 Jul; 7(7):631-6. PubMed ID: 12870683 [Abstract] [Full Text] [Related]
43. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR, Agarwal SK, Shah KV. Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [Abstract] [Full Text] [Related]
44. Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia. Riekstina V, Leimane V, Holtz TH, Leimans J, Wells CD. Int J Tuberc Lung Dis; 2007 May; 11(5):585-7. PubMed ID: 17439686 [Abstract] [Full Text] [Related]
45. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital. Liu CH, Yang N, Wang Q, Hu YL, Li L, Zhang GY, Zhu B. Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401 [Abstract] [Full Text] [Related]
46. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, Rüsch-Gerdes S, Kebede Y. Clin Infect Dis; 2007 Jun 01; 44(11):1421-7. PubMed ID: 17479936 [Abstract] [Full Text] [Related]
47. Clinical characteristics of pulmonary tuberculosis patients from a southern Taiwan hospital-based survey. Wang CS, Chen HC, Yang CJ, Tsai JR, Chong IW, Hwang JJ, Huang MS. Kaohsiung J Med Sci; 2008 Jan 01; 24(1):17-24. PubMed ID: 18218565 [Abstract] [Full Text] [Related]
48. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Kang MW, Kim HK, Choi YS, Kim K, Shim YM, Koh WJ, Kim J. Ann Thorac Surg; 2010 May 01; 89(5):1597-602. PubMed ID: 20417785 [Abstract] [Full Text] [Related]
49. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Al-Rubaish AM, Madania AA, Al-Muhanna FA. Saudi Med J; 2001 Sep 01; 22(9):776-9. PubMed ID: 11590451 [Abstract] [Full Text] [Related]
50. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Amiri M, Mansouri D, Masjedi MR, Velayati AA, Caminero JA. Microb Drug Resist; 2010 Mar 01; 16(1):81-6. PubMed ID: 20192820 [Abstract] [Full Text] [Related]
51. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000]. Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H. Arch Inst Pasteur Madagascar; 2002 Mar 01; 68(1-2):44-7. PubMed ID: 12643091 [Abstract] [Full Text] [Related]
53. Pilot study on multidrug resistant tuberculosis in Nigeria. Lawson L, Habib AG, Okobi MI, Idiong D, Olajide I, Emenyonu N, Onuoha N, Cuevas LE, Ogiri SO. Ann Afr Med; 2010 Mar 01; 9(3):184-7. PubMed ID: 20710112 [Abstract] [Full Text] [Related]
54. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso. Sangare L, Diande S, Kouanda S, Dingtoumda BI, Mourfou A, Ouedraogo F, Sawadogo I, Nebie B, Gueye A, Sawadogo LT, Traore AS. Ann Afr Med; 2010 Mar 01; 9(1):15-9. PubMed ID: 20418644 [Abstract] [Full Text] [Related]
55. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey. Talay F, Kumbetli S, Altin S. Jpn J Infect Dis; 2008 Jan 01; 61(1):25-30. PubMed ID: 18219130 [Abstract] [Full Text] [Related]
56. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Int J Tuberc Lung Dis; 2000 Feb 01; 4(2):108-14. PubMed ID: 10694087 [Abstract] [Full Text] [Related]
57. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome. Karagöz T, Yazicioğlu Moçin O, Pazarli P, Senol T, Yetiş Duman D, Duman G, Saltürk C, Unal O, Halezeroğlu S. Tuberk Toraks; 2009 Feb 01; 57(4):383-92. PubMed ID: 20037853 [Abstract] [Full Text] [Related]
58. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China. Qi W, Harries AD, Hinderaker SG. Int J Tuberc Lung Dis; 2011 Jan 01; 15(1):137-9. PubMed ID: 21276311 [Abstract] [Full Text] [Related]
59. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis. Törün T, Tahaoğlu K, Ozmen I, Sevim T, Ataç G, Kir A, Güngör G, Bölükbaşi Y, Maden E. Int J Tuberc Lung Dis; 2007 Sep 01; 11(9):979-85. PubMed ID: 17705975 [Abstract] [Full Text] [Related]
60. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China]. Shen X, Li J, Gao Q, Xu B, Mei J. Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun 01; 34(6):451-3. PubMed ID: 21781519 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]